sandra-Challma

Unraveling Alzheimer’s: Confronting the Effect on Mortality

Today, Alzheimer’s is one of the most prevalent diseases in America, affecting about 11.3% of all people aged 65 years and over. In 2021, there were about 6.2 million people with Alzheimer’s, with the number expected to more than double and reach 13 million by 2050 should a cure not be found. It typically affects the seniors, with 72% of the 6.2 million people living with Alzheimer’s being over 75 years old.

Unraveling Alzheimer’s: Confronting the Effect on Mortality Read More »

Alzheimer’s Diagnosis Accessibility: A Need for Earlier Diagnosis and a Better Life

In 2021, more than 6 million people were living with Alzheimer’s in the US. This number is projected to more than double to over 13 million by 2050. Despite the exceedingly high number of Alzheimer’s patients, the cost of diagnosis and treatment is also very high, making it one of the costliest ailments in the world. As a result, proper diagnosis and treatment are way off the reach of thousands of Americans, with this number also projected to rise.

Alzheimer’s Diagnosis Accessibility: A Need for Earlier Diagnosis and a Better Life Read More »

Middle aged couple walking

Alzheimer’s and the Benefits of Early Diagnosis

According to the Alzheimer’s Association, more than 6 million Americans aged 65 years and older live with Alzheimer’s. This number is expected to more than double, hitting about 13 million people by 2050. This translated to about one in nine people over the age of 65, or 11.3% of Americans have dementia. And the numbers are just as staggering around the globe. 

Alzheimer’s and the Benefits of Early Diagnosis Read More »

Alzheimer’s Crisis: Revolutionary Early Detection Saves Lives and Eases Families’ Burdens

Every year 10 million people are diagnosed with Alzheimer’s disease. Yet the number of people who remain undiagnosed is far greater. The rate of diagnosis is especially poor in the early stages of the disease. According to recent estimates, around 80% of patients fail to be diagnosed in the initial stages.

Alzheimer’s Crisis: Revolutionary Early Detection Saves Lives and Eases Families’ Burdens Read More »

Scan

Optimizing Assessment of Function in Early Alzheimer’s Disease

Alzheimer’s disease is one of the most common diseases affecting cognitive processes. According to studies, millions of Alzheimer’s cases go undiagnosed due to the inefficiency of invasive diagnostic procedures, as well as the costly treatments that go with it. Alzheimer’s is commonly thought to be a disease that exclusively affects the elderly, however, it may afflict persons of any gender or age.

Optimizing Assessment of Function in Early Alzheimer’s Disease Read More »

Scroll to Top